Article
Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.
European journal of haematology - 1 Oct 2012
Puig Noemí, Sarasquete María E, Alcoceba Miguel, Balanzategui Ana, Chillón María C, Sebastián Elena, Díaz Marcos G, San Miguel Jesús F, García-Sanz Ramón
Abstract excerpt
BACKGROUND AND OBJECTIVES: Minimal residual disease (MRD) assessment by PCR in multiple myeloma (MM) has several shortcomings, including the lack of a suitable target. Kappa deleting element (KDE) rearrangements occur in virtually all Ig-lambda B-cell malignancies and in 1/3 of Ig-kappa are not affected by somatic hypermutation and, as in ALL, could be used as PCR targets. METHODS: We have first investigated the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
